Literature DB >> 11464975

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review.

T Hahn1, S N Wolff, M Czuczman, R I Fisher, H M Lazarus, J Vose, L Warren, R Watt, P L McCarthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11464975     DOI： 10.1016/s1083-8791(01)80003-3

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  9 in total

Review 1.  Treatment of aggressive non-Hodgkin's lymphoma with chemotherapy in combination with filgrastim.

Authors:  Jeff Schriber
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Fast Cars and No Brakes: Autologous Stem Cell Transplantation as a Platform for Novel Immunotherapies.

Authors:  Miguel-Angel Perales; Craig S Sauter; Philippe Armand
Journal:  Biol Blood Marrow Transplant       Date:  2015-10-17       Impact factor: 5.742

3.  SEOM clinical guidelines for the treatment of diffuse large B-cell lymphoma.

Authors:  José Gómez Codina; Pilar Sabín Domínguez; Mariano Provencio Pulla; Antonio Rueda Domínguez; Dolores Isla Casado
Journal:  Clin Transl Oncol       Date:  2010-11       Impact factor: 3.405

4.  Exercise in patients receiving hematopoietic stem cell transplantation: lessons learned and results from a feasibility study.

Authors:  Eileen Danaher Hacker; Janet L Larson; David Peace
Journal:  Oncol Nurs Forum       Date:  2011-03       Impact factor: 2.172

Review 5.  NHL (diffuse large B-cell lymphoma).

Authors:  Mark Hill; Fiona Kyle
Journal:  BMJ Clin Evid       Date:  2010-11-15

Review 6.  NHL (diffuse large B cell lymphoma).

Authors:  Fiona Kyle; Mark Hill
Journal:  BMJ Clin Evid       Date:  2008-01-18

7.  Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee.

Authors:  Akshay Sharma; Sherif M Badawy; Elizabeth M Suelzer; Hemant S Murthy; Pinki Prasad; Hesham Eissa; Paul A Carpenter; Mehdi Hamadani; Myriam Labopin; Hélène Schoemans; André Tichelli; Rachel Phelan; Betty K Hamilton; David Buchbinder; Annie Im; Rebecca Hunter; Ruta Brazauskas; Linda J Burns
Journal:  Transplant Cell Ther       Date:  2021-01-28

Review 8.  High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults.

Authors:  A Greb; J Bohlius; D Schiefer; G Schwarzer; H Schulz; A Engert
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

9.  Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.

Authors:  Robin M Reid; Andrea Baran; Jonathan W Friedberg; Gordon L Phillips; Jane L Liesveld; Michael W Becker; Lucy Wedow; Paul M Barr; Laurie A Milner
Journal:  Cancer Med       Date:  2016-10-03       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.